Tasigna Atherosclerosis Lawsuit News

Tasigna's Side Effects Require Special Attention From Prospective Patients

When sudden death, amputation, and strokes are taken into account, few patients have been properly informed of the risks of Tasigna

Monday, August 6, 2018 - Cancer patients must make life and death decisions about the type of chemotherapy treatment they will receive and are entitled to all of the facts pertaining to a drug's side effects. This way cancer sufferers can make informed decisions in terms of the risks and benefits an anti-cancer chemotherapy drug carries.

Cancer patients suffer from all of the well-known chemotherapy side effects such as hair loss, nausea, lethargy, skin lesions, and many more, none of which are life-threatening in and of themselves. Cancer patients that were given Tasigna, however, were kept in the dark as to the life and death side effects of the drug as well as the amputation risks. In addition to all of the other side effects, Tasigna patients face sudden death from heart attack, permanent paralysis from strokes, and amputation of the lower leg, foot and toes due to necrosis (tissue death).

Tasigna patients are warned on every bottle of Tasigna and on the official Tasigna website that the drug causes an unforeseen deadly side effect called QT Prolongation. The FDA requires that Tasigna carry a black box warning which is reserved for only drugs that have the potential for causing severe injury or death. Novartis, the maker of Tasigna, admits that the drug causes "sudden death." The QT is simply the interval of time in between heartbeats. Increasing this interval can cause the heart to stop beating altogether. In addition to the black box warning Tasigna is required to advise doctors to thoroughly screen potential patients for the signs of pre-existing heart conditions or blood abnormalities and if positive to refrain from using Tasigna. Healthy patients are required to be given an electrocardiogram (EKG) in order to establish a baseline. That number is compared with future EKGs given to healthy Tasigna patients during and after treatment begins and afterward on a regular monthly basis for at least two years. While monitoring a patient for signs of irregular heartbeat is important, keeping an eye out for another deadly disease related to Tasigna can be equally critical. An unusually high number of Tasigna patients are developing atherosclerosis.

Cases of atherosclerosis, a narrowing, and thickening of the arteries have been reported in an unacceptable number of Tasigna patients. In cases of rapid-onset atherosclerosis, the passageways to the extremities, brain, and heart become narrow and as a result, less and less blood circulates to the lower legs, feet, toes, and vital organs. When a chunk of the fatty-plaque clogging the artery breaks free it can cause a clot and block blood flow and cause a stroke or a heart attack.

While the common symptoms of chemotherapy go away shortly after a patient is in cancer remission and stops treatments, a Tasigna patient's health continues to be in grave danger long afterward. Atherosclerosis is a permanent and irreversible condition. Without drugs and a proper diet, atherosclerosis can amount to a death sentence, hardly worth the efforts one has to put forth battling cancer. Patient suffering from atherosclerosis are encouraged to consult with a Tasigna atherosclerosis attorney to determine whether or not they can file a claim against Novartis for rushing an untested and unproven drug to market.

More Recent Tasigna Atherosclerosis Lawsuit News:

Lawyers for Tasigna Atherosclerosis Lawsuits

Attorneys handling Tasigna lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Tasigna lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Tasigna lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.